Managements in hospital from admission to 6 months
| Variables | ACS | SCAD | Total | P values |
| (n=364) | (n=113) | (n=477) | ||
| Onset to admission (hours) | 24 (9–48) | 36 (16.3–72) | 26.8 (10–48) | 0.002 |
| Length of hospitalisation (days) | 7 (5–10) | 1 (0–7) | 6 (4–9) | <0.001 |
| Admission to intervention (hours) | 120 (8–168) | 8 (4–149.6) | 96 (8–149.6) | <0.001 |
| Invasive treatment | ||||
| Thrombolysis | 13 (3.6) | NA | 13 (2.7) | NA |
| Primary PCI | 10 (2.7) | NA | 10 (2.1) | NA |
| Elective PCI | 47 (12.9) | 32 (28.3) | 79 (16.6) | 0.003 |
| CABG+PCI* | 2 (0.5) | 0 (0.0) | 2 (0.4) | 1 |
| CAG only | 124 (34.1) | 58 (51.3) | 182 (38.2) | 0.001 |
| No exploration | 181 (49.7) | 23 (20.4) | 204 (42.8) | <0.001 |
| Pharmacotherapy | ||||
| Anticoagulant | 168 (46.2) | 16 (14.2) | 184 (38.6) | <0.001 |
| ASA | 320 (87.9) | 74 (65.5) | 394 (82.6) | <0.001 |
| Clopidogrel | 308 (84.6) | 58 (51.3) | 366 (76.7) | <0.001 |
| Statin | 271 (74.5) | 54 (47.8) | 325 (68.1) | <0.001 |
| Hypertension medication | 263 (72.3) | 80 (70.8) | 343 (71.9) | 0.123 |
Values are n (%) and medians (Q1–Q3). Comparison was done using Mann-Whitney U test for continuous variables and Pearson χ2 test for categorical variables.
*Comparison was done using Fisher’s exact test.
ACS, acute coronary syndrome; ASA, acetylsalicylic acid; CABG, coronary artery bypass graft surgery; CAG, coronary angiography; NA, not applicable; PCI, percutaneous coronary intervention; SCAD, stable coronary artery disease.